Advertisement
Advertisement
U.S. markets open in 6 hours 16 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Northwest Biotherapeutics, Inc. (NWBO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.6950+0.0021 (+0.30%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6929
Open0.7090
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6630 - 0.7199
52 Week Range0.3900 - 2.0500
Volume3,542,794
Avg. Volume4,118,050
Market Cap684.052M
Beta (5Y Monthly)0.05
PE Ratio (TTM)N/A
EPS (TTM)-0.0630
Earnings DateAug 08, 2020 - Aug 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NWBO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NORTHWEST BIOTHERAPEUTICS INC
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement